İlhan Hacıbekiroğlu

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Sun Young Rha, Do‐Youn Oh, Patricio Yañez et al. · The Lancet Oncology · 2023 · 521 citations

Chemotherapy Versus Placebo, Gastrointestinal Oncology, Medicine +8

Efficacy and Safety Profile of COVID-19 Vaccine in Cancer Patients: A Prospective, Multicenter Cohort Study

Ayşe İrem Yasin, Sabin Göktaş Aydın, Bilge Sümbül et al. · Future Oncology · 2022 · 31 citations · Full text

K-RAS and N-RAS mutations in testicular germ cell tumors

Muhammet Bekir Hacıoğlu, Hilmi Kodaz, Bülent Erdoğan et al. · Bosnian Journal of Basic Medical Sciences · 2017 · 28 citations · Full text

Ras Gene Mutations, Kirsten Ras, N-ras Mutations +14

Clinicopathological Characteristics and Prognosis of Patients According to Recurrence Time After Curative Resection for Colorectal Cancer

Oktay Bozkurt, Mevlüde İnanç, Esma Türkmen et al. · Asian Pacific Journal of Cancer Prevention · 2014 · 25 citations · Full text

Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumors

Hilmi Kodaz, İlhan Hacıbekiroğlu, Bülent Erdoğan et al. · Molecular and Clinical Oncology · 2014 · 25 citations · Full text

Gastroenterology, Pathology, Tumor Biology +17